#Germany #Milan #Spine Surgery #Demetra #Maxxspine

Demetra Strengthens Spine Surgery Position with Maxxspine Acquisition

Demetra, a leading international medical company renowned for its innovative orthopedic solutions, has made headlines with its recent acquisition of Maxxspine Innovative GmbH. Established more than twenty years ago, Maxxspine has carved a niche in advanced spinal surgery solutions, making this acquisition a significant milestone for both firms.

Enhancing Market Leadership

The acquisition was completed successfully by Osartis GmbH, a subsidiary of the Demetra group, which now holds 100% ownership of Maxxspine. This move is expected to solidify Demetra's position as a benchmark in spinal surgery by integrating Maxxspine's innovative technologies and products into its extensive portfolio. Founded in 2010 in Germany, Maxxspine specializes in developing and distributing cutting-edge medical devices specifically for spinal surgery, and has built a reputation not only in the German market but also internationally.

With this acquisition, Demetra significantly expands its range of spine products while also increasing its accessibility to surgeons and medical professionals across key European markets and beyond. As a company with a legacy of over 40 years, Demetra has continuously provided advanced solutions in infection control, prosthetic fixation, orthobiology, and minimally invasive surgeries. It is estimated that more than three million patients worldwide have benefitted from Demetra’s innovative medical solutions.

Strategic Steps Towards Continued Growth

Following the merger, Osartis will assume global responsibilities for Maxxspine’s operations. The cooperation between the existing Maxxspine management and Osartis is intended to ensure a seamless integration process that prioritizes service continuity for customers and partners alike. Volker Ludwig, the CEO of Maxxspine, expressed optimism about the acquisition, highlighting that joining forces with Demetra provides a robust platform for advancing their collective vision. He emphasized the importance of trust and professionalism, which have been central to Maxxspine's approach, and is confident that these values will continue to thrive post-acquisition.

Maxxspine’s extensive experience in developing bespoke surgical solutions for spine treatment means that it’s well-positioned for navigating the next phase of strategic growth. The company aims to enhance its capabilities, reach, and strength as a dependable partner for both clients and suppliers. The partnership with Demetra, according to Ludwig, opens the door to new opportunities in areas like kyphoplasty, setting the stage for growth in an evolving marketplace.

A Vision for Future Opportunities

CEO Michele Perrino of Demetra stated that acquiring Maxxspine aligns perfectly with the company’s strategic objective of bolstering its presence in vital European spinal surgery markets. The integration of specialized companies like Maxxspine is seen as a substantial step towards improving Demetra's ability to deliver innovative solutions tailored to meet the needs of surgeons and patients. This acquisition helps Demetra enhance its role as a trusted international partner in spinal healthcare, an area of growing importance.

Demetra is committed to investing in people, research, and sustainable innovation, maintaining its focus on improving patient care through the development of effective medical solutions. With a presence in over 100 countries and a portfolio of patented technologies on the rise, Demetra continues to prioritize advancements that position it favorably in the global medical device industry.

Through this acquisition, Demetra emphasizes its dedication toward fostering meaningful partnerships with healthcare professionals worldwide while continuously pushing the boundaries of what’s possible in the medical sector.